News & analysis, rated.
Breaking AI developments, in-depth guides, real-world case studies, and analysis — each one rated so you know what matters.
Four PE giants bid $1.2B for 25% stake in India's largest maternity chain
TPG Capital, Advent International, CVC and Permira shortlisted to acquire minority stake in Cloudnine, valued at ₹11,000 crore. Binding bids due early August.
India's ICMR launches outbreak analytics platform to speed epidemic response
ICMR-NIE unveiled ADARV, a data analytics platform that cuts outbreak analysis from days to hours without requiring specialized statisticians. Built with IISc partners, it aims to shift India's public health data from silos to shared intelligence.
India's private hospitals publish 6x fewer papers than peers with medical schools
Top 50 private hospitals without medical colleges averaged 242 publications over 5 years vs. 1,530 for those with colleges. Private sector handles 60% of patient volume but contributes minimal research.
India pledges $10M to Ebola response as G7 warns of global health risk
India announced $10 million in funding at an African Union summit to support Ebola preparedness and response in Africa. The pledge includes 45 tonnes of medical supplies already delivered and capacity-building support.
India cuts child stunting 6% in 3 years, but obesity in women surges
NFHS-6 survey shows stunting fell to 29.3% from 35.5%, while maternal healthcare access hit 90.6% institutional births. But women's obesity jumped to 30.7%, signaling a dual nutrition crisis ahead.
Bajaj Health System Deploys Philips Data Platform to Link Patient Records
BIHS will use Philips' IntelliBridge Enterprise 3.0 to connect medical devices and hospital systems across clinics and home care. First global deployment of the cloud platform launches in 2026.
Edgewise heart drug clears trial, but efficacy vs rivals stays murky
Edgewise Therapeutics' EDG-7500 passed a key trial for hypertrophic cardiomyopathy. The gap between this drug and existing treatments from Bristol Myers Squibb and Cytokinetics remains unclear.
FDA staff flags gaps in Moderna flu vaccine data ahead of advisory vote
Ahead of Thursday's advisory committee meeting, FDA scientists detailed shortcomings in Moderna's flu vaccine evidence. The agency had refused to review the shot earlier this year.
Express Scripts sues to block Tennessee PBM breakup law
Express Scripts and pharmacy benefit manager lobby groups filed suit against Tennessee's FAIR Rx Act, which forces separation of PBM and pharmacy operations. CVS Caremark already challenged the law in court.
Lilly Acquires 4E for Non-Opioid Pain Drug Pipeline
Eli Lilly bought pain-drug developer 4E in the latest of $18B+ in acquisitions over recent years. The deal signals Lilly's bet on non-opioid alternatives as regulatory pressure on opioids grows.
Vedana Raises $46M for Anti-PACAP Migraine Therapies
Vedana Therapeutics launched Wednesday with $46 million in Westlake-backed funding to develop anti-PACAP treatments for migraine prevention. Here's why the strategy is gaining traction in biotech.
CMS proposes Medicare coverage for TAVR, tilting competition toward Edwards
Centers for Medicare & Medicaid Services proposed expanding coverage for transcatheter aortic valve replacement. The move could shift market share among device makers.